Adverse Drug Reaction News Bulletins
ADR News Bulletin 2013 December (Volume 15 Number 3)
Audiences
Healthcare professional
Industry member
Product type
Therapeutic Products
1 December 2013
This article has been migrated from an earlier version of the site and may display formatting inconsistencies.
Bulletin Highlights:
Contraindication of subcutaneous administration of Eprex® (epoetin alfa) in Singapore in chronic kidney disease patients
Safety update on hydroxyethyl starch (HES)-containing products
Recommendations to avoid use of glibenclamide in the elderly and renal-impaired
Update on strontium ranelate (Protos®): Risk of cardiac events and enhancing awareness of the local risk management plan to mitigate the risk of serious skin reactions
HLA-B*1502 genotype testing: Towards safer use of carbamazepine
Reports of febrile seizures with measles, mumps, rubella and varicella (MMRV) combination vaccine
Safety advisory on cyproterone acetate/ethinylestradiol
List of Dear Healthcare Professional Letters (DHCPL) issued by HSA, pharmaceutical and medical device companies
Neurologic and psychiatric adverse reactions associated with mefloquine
Click on the link below to download the issue in pdf:
ADR_News_Dec2013_Vol15_No3 [PDF, 429 KB]